Evaluation of Leptin hormone and magnesium levels in recently diagnosed migraine patients
Abstract
Background: Migraine episodes are associated with multiple severe debilitating headaches. Several factors and triggers determine migraine pathogenesis. Adipocytokines and magnesium are substantially involved in migraine pathogenesis. Objectives: Assessment of leptin and magnesium levels in patients recently diagnosed with migraine. Subjects and methods: It was done at period from January 2023 to May 2024 at Zagazig University Hospitals, Egypt; 63 recently diagnosed patients with migraine were presented within this case - control study, the level of leptin was measured and magnesium and compared the results with 66 healthy individuals who did not have any headache, renal, or gastrointestinal disorders, and no intake of magnesium tablets nor medications interfering with leptin metabolism. Results: Recently diagnosed migraine patients had leptin levels significantly less than the control individuals (39.8 ± 20.7, 48.9 ± 23.6; P < .05). The average magnesium levels were 0.8±0.3 in Migrainers, whereas controls showed higher levels 1.9±0.2 (average normal value: 1.8 – 2.3 mg/dl) (p<.001). Conclusions: Recently Migrainers had lower leptin hormone values in between migraine episodes than that of healthy individuals. The magnesium measurements were lower significantly in migrainers than in healthy subjects, and this indicated that deficiency of magnesium involved in migraine pathophysiology and episodes.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.